Abstract
Pseudogenes have for long been considered as non-functional relics littering the human genome. Only now, it is becoming apparent that many pseudogenes are transcribed into long noncoding RNAs, some with proven biological functions. Here, we review the current knowledge of pseudogenes and their widespread functional properties with an emphasis on pseudogenes that have been functionally investigated in greater detail. Pseudogenes are emerging as a novel class of long noncoding RNAs functioning, for example, through microRNA sponging and chromatin remodeling. The examples discussed herein underline that pseudogene-encoded RNAs are important regulatory molecules involved in diseases such as cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ohshima K et al (2003) Whole-genome screening indicates a possible burst of formation of processed pseudogenes and Alu repeats by particular L1 subfamilies in ancestral primates. Genome Biol 4:R74
Pei BK et al (2012) The GENCODE pseudogene resource. Genome Biol 13:R51
Hayashi H et al (2013) The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer. Oncogene 34:199–208
Johnsson P et al (2013) A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 20:440–446
Alimonti A et al (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42:454–458
Baillie JK et al (2011) Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479:534–537
Balasubramanian S et al (2009) Comparative analysis of processed ribosomal protein pseudogenes in four mammalian genomes. Genome Biol 10:R2
Batzer MA, Deininger PL (2002) Alu repeats and human genomic diversity. Nat Rev Genet 3:370–379
Beltran M et al (2008) A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22:756–769
Brockdorff N et al (1992) The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71:515–526
Brown CJ et al (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527–542
Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Foti D (2001) Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J 15:492–500
Carninci P et al (2005) The transcriptional landscape of the mammalian genome. Science 309:1559–1563
Chan WL, Yang WK, Huang HD, Chang JG (2013) pseudoMap: an innovative and comprehensive resource for identification of siRNA-mediated mechanisms in human transcribed pseudogenes. Database (Oxford) 2013:bat001
Chen J et al (2004) Over 20 % of human transcripts might form sense-antisense pairs. Nucleic Acids Res 32:4812–4820
Chiappetta G et al (1995) The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10:1307–1314
Chiappetta G et al (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439–2446
Chiefari E et al (2010) Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun 1:40
Chieffi P et al (2002) HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene 21:3644–3650
Cooke SL et al (2014) Processed pseudogenes acquired somatically during cancer development. Nat Commun 5:3644
Coufal NG et al (2009) L1 retrotransposition in human neural progenitor cells. Nature 460:1127–1131
Dahia PL et al (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16:2403–2406
Djebali S et al (2012) Landscape of transcription in human cells. Nature 489:101–108
Duret L, Chureau C, Samain S, Weissenbach J, Avner P (2006) The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene. Science 312:1653–1655
Engstrom PG et al (2006) Complex Loci in human and mouse genomes. PLoS Genet 2:e47
Esnault C, Maestre J, Heidmann T (2000) Human LINE retrotransposons generate processed pseudogenes. Nat Genet 24:363–367
Esposito F et al (2014) HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 5:8341–8354
Feng Q, Moran JV, Kazazian HH Jr, Boeke JD (1996) Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87:905–916
Foti D et al (2005) Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11:765–773
Frasca F et al (2006) HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res 66:2980–2989
Frith MC et al (2006) Pseudo-messenger RNA: phantoms of the transcriptome. PLoS Genet 2:e23
Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899–910
Giancotti V et al (1985) Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res 45:6051–6057
Gong CG, Maquat LE (2011) lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elements. Nature 470:284–288
Grosschedl R, Giese K, Pagel J (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10:94–100
Gupta RA et al (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071–1076
Hacisuleyman E et al (2014) Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre. Nat Struct Mol Biol 21:198–206
Hata K, Sakaki Y (1997) Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 189:227–234
Hawkins PG, Morris KV (2010) Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription 1:165–175
Iskow RC et al (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141:1253–1261
Jacq C, Miller JR, Brownlee GG (1977) A pseudogene structure in 5S DNA of Xenopus laevis. Cell 12:109–120
Johnsson P, Morris KV, Grander D (2014) Pseudogenes: a novel source of trans-acting antisense RNAs. Methods Mol Biol 1167:213–226
Kalyana-Sundaram S et al (2012) Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 149:1622–1634
Kastler S et al (2010) POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate 70:666–674
Katayama S et al (2005) Antisense transcription in the mammalian transcriptome. Science 309:1564–1566
Khoo C, Blanchard RK, Sullivan VK, Cousins RJ (1997) Human cysteine-rich intestinal protein: cDNA cloning and expression of recombinant protein and identification in human peripheral blood mononuclear cells. Protein Expr Purif 9:379–387
Kim TK et al (2010) Widespread transcription at neuronal activity-regulated enhancers. Nature 465:182–187
Korneev SA, Park JH, O’Shea M (1999) Neuronal expression of neural nitric oxide synthase (nNOS) protein is suppressed by an antisense RNA transcribed from an NOS pseudogene. J Neurosci 19:7711–7720
Lander ES et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921
Latos PA et al (2012) Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science 338:1469–1472
Lee JT, Davidow LS, Warshawsky D (1999) Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 21:400–404
Lee E et al (2012) Landscape of somatic retrotransposition in human cancers. Science 337:967–971
Levy S et al (2007) The diploid genome sequence of an individual human. PLoS Biol 5:e254
Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kogler G (2007) Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1:364–366
Liu YJ et al (2009) Comprehensive analysis of the pseudogenes of glycolytic enzymes in vertebrates: the anomalously high number of GAPDH pseudogenes highlights a recent burst of retrotrans-positional activity. BMC Genom 10:480
Mahmoudi S et al (2009) Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 33:462–471
Margulies EH et al (2005) Comparative sequencing provides insights about the structure and conservation of marsupial and monotreme genomes. Proc Natl Acad Sci USA 102:3354–3359
Mathias SL, Scott AF, Kazazian HH Jr, Boeke JD, Gabriel A (1991) Reverse transcriptase encoded by a human transposable element. Science 254:1808–1810
McClintock B (1950) The origin and behavior of mutable loci in maize. Proc Natl Acad Sci USA 36:344–355
Mestdagh P et al (2010) An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene 29:3583–3592
Moran JV et al (1996) High frequency retrotransposition in cultured mammalian cells. Cell 87:917–927
Morris KV, Mattick JS (2014) The rise of regulatory RNA. Nat Rev Genet 15:423–437
Muotri AR et al (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature 468:443–446
Muro EM, Andrade-Navarro MA (2010) Pseudogenes as an alternative source of natural antisense transcripts. Bmc Evol Biol 10:338
Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372–376
Pain D, Chirn GW, Strassel C, Kemp DM (2005) Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem 280:6265–6268
Pegoraro S et al (2013) HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget 4:1293–1308
Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N (1996) Requirement for Xist in X chromosome inactivation. Nature 379:131–137
Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271–278
Phokaew C, Kowudtitham S, Subbalekha K, Shuangshoti S, Mutirangura A (2008) LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic Acids Res 36:5704–5712
Pierantoni GM et al (2001) High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20:6132–6141
Pierantoni GM et al (2003) High-mobility group A1 proteins are overexpressed in human leukaemias. Biochem J 372:145–150
Pierantoni GM et al (2007) High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 117:693–702
Poliseno L et al (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465:1033–1038
Poliseno L et al (2011) Deletion of PTENP1 pseudogene in human melanoma. J Invest Dermatol 131:2497–2500
Puget N et al (2002) Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 70:858–865
Rapicavoli NA et al (2013) A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife 2:e00762
Reeves R, Nissen MS (1990) The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265:8573–8582
Rinn JL et al (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129:1311–1323
Sado T, Wang Z, Sasaki H, Li E (2001) Regulation of imprinted X-chromosome inactivation in mice by Tsix. Development 128:1275–1286
Sleutels F, Zwart R, Barlow DP (2002) The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415:810–813
Solyom S et al (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22:2328–2338
Stoger R et al (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73:61–71
Suo G et al (2005) Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 337:1047–1051
Tai MH et al (2005) Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26:495–502
Takeda J, Seino S, Bell GI (1992) Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20:4613–4620
Tam OH et al (2008) Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 453:534–538
Taylor SI et al (1992) Mutations in the insulin receptor gene. Endocr Rev 13:566–595
Taylor SI, Accili D, Imai Y (1994) Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43:735–740
Tessari MA et al (2003) Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol 23:9104–9116
Thanos D, Maniatis T (1992) The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 71:777–789
Wang L et al (2013) Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis 34:1773–1781
Watanabe T et al (2008) Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 453:539–543
Weil D, Power MA, Webb GC, Li CL (1997) Antisense transcription of a murine FGFR-3 psuedogene during fetal developement. Gene 187:115–122
Wutz A et al (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389:745–749
Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137:647–658
Yu W et al (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451:202–206
Zakut-Houri R et al (1983) A single gene and a pseudogene for the cellular tumour antigen p53. Nature 306:594–597
Zangrossi S et al (2007) Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25:1675–1680
Zhang ZL, Carriero N, Gerstein M (2004) Comparative analysis of processed pseudogenes in the mouse and human genomes. Trends Genet 20:62–67
Zhao S et al (2011) Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. J Pathol 223:672–682
Zhou BS, Beidler DR, Cheng YC (1992) Identification of antisense RNA transcripts from a human DNA topoisomerase I pseudogene. Cancer Res 52:4280–4285
Acknowledgments
Research reported in this publication was supported by the Swedish Childhood Cancer Foundation, The Swedish Cancer Society, Radiumhemmets Forskningsfonder, Vetenskapsrådet to Dan Grandér.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Grandér, D., Johnsson, P. (2015). Pseudogene-Expressed RNAs: Emerging Roles in Gene Regulation and Disease. In: Morris, K. (eds) Long Non-coding RNAs in Human Disease. Current Topics in Microbiology and Immunology, vol 394. Springer, Cham. https://doi.org/10.1007/82_2015_442
Download citation
DOI: https://doi.org/10.1007/82_2015_442
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23906-4
Online ISBN: 978-3-319-23907-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)